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1012-131 Long-Term Effect  o f  ACE Inh ib i tor  on Chronic Mitrel 
Regurgitation 
Hae-Youno Lee. Hyun-Jai Cho, In-Ho Chae, Myung-Mook Lee, Department of Internal 
Medicine, Seou/ National University College of Medicine, Seoul, South Korea, 
Cardiovascular/aborato~ Clinical Research/nstitute, Seou/ National University Hospital, 
Seoo/, South Korea. 
Background: Angiotensin converting enzyme inhibitors(ACEI) have been suggested to 
be beneficial in regurgitant valvular heart disease by reducing both preload and aftedoad. 
Moreover its beneficial effects have been proven also in acute mitral regurgitation. How- 
ever the role of ]ong term administration of ACE inhibitors in chronic mitral regurgitation 
has been disputable. 
Materials and Methods: 100 patients with moderate to severe MR were identified from 
patients undergoing cardiac echocardiogrephy between April 1984 and July 2000. 
Patients with co-morbid valvular heart disease more than mild degrees were excluded 
from the study. They were divided into the study group (who took Captopdl or Enalapril) 
and control group. Medical records and echocardiographic reports were reviewed and 
etiology of mitral regurgitation, left ventricular end-diastolic demensions(LVEDD) and 
end-systolic demensions(LVESD), left atirel demensions, and ejection fraction(EF) 
changes were studied serially for both groups 
Results: The mean duration of follow-up was 5.0±3.2 years. There were no significant 
differences in age, blood pressure, basal echocardiographic parameters in the rheumatic 
mitral regurgitation (Rheumatic MR) and mitral valve prolapse (MVP) groups. In MVP 
patients, ACEI group showed statistically significant increase in EF (p=0.007), decrease 
in LVESD (p=0.0014) and decrease in left atrial demensions (p=0.01). But in Rheumatic 
MR patients, ACEI group showed no significant changes compared to those of non-ACEI 
group. 
Conclusion: Long term angiotensin converting enzyme inhibitor therapy seems to be 
beneficial in mitral regurgitation due to mitral valve prolapse. 
1012-132 Effect of Left Ventricular Size Regression on Mltral 
Valve Function and Anatomy 
Husam Noor. Liset Stoletniy, Ramesh C. Bansal, Ramdas G. Pal, Loma Linda University 
Medical Center, Loma Linda, California. 
Background: Mitral regurgitation (MR) is common in congestive heart failure (CHF) and 
adversely affects symptoms and prognosis. Its precise mechanism and the effect on it of 
left ventricular (LV) size regression with aggressive medical therapy is not known. 
Methods: Twenty-one patients with CHF who had marked improvement in LV size and 
function (LV end-diastolic diameter decrease of >10 mm and ejection fraction increase of 
>20%,) with aggressive medical therapy formed the study group, Echocardiograms 
before and after therapy were quantitatively analyzed for mitrat annulus diameter, leaflet 
length and thickness, mitral valve (MV) apical tenting distance as the distance of the 
coaptation point from the annular plane, MV apical tenting area as the area contained by 
mitral leaflets and the annular plane, leaflet excursion angles, interpapillary muscle dis- 
tance, LV diameters and ]eff atrial size. 
Results: The mean age was 59 years, 40% women. The results are summarized. 
Variable Pre-LV Post-LV P Value 
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1012-133 Loss of Annular Saddle Shape Is Associated With Acute 
Ischemlc Mitral Regurgitation 
Joseph H. Gorman, III, Benjamin M. Jackson, Sina L. Moainie, T. Sloane Guv. IV, Martin 
St. John-Sutton, L. Henry Edmunds, Robert C. Gorman, University of Pennsylvania, 
Philadelphia, Pennsylvania. 
Background: During the past several years an increasing awareness of the saddle shape 
of the mitral annulus has developed. This shape is preserved across several mammalian 
species. A recent finite element model has shown that this annular shape imposes leaflet 
curvature that in combination with leaflet bulging reduces stress during systole. These 
findings indicate a possible contribution of annular shape to valve competence. Using an 
ovine model and sonomicrometry array localization (SAL) imaging, we tested the hypoth- 
esis that loss annular saddle shape is associated with acute ischemic mitral regurgitation 
(AIMR). Methods: On bypass, six piezoelectric transducers were equally spaced around 
the mitral annulus in 5 sheep. In addition, snares were placed around 3 branches of the 
cimumflex artery. After instrumentation snares were tightened to produce an infarction of 
32% of the LV, creating 2 to 3+ MR acutely. The saddle shape of each annulus was quan- 
tified using an annular height to commissural width ratio(AHCWR). This value was calcu- 
lated by dividing the height of the annulus perpendicular to the valve plane by the intra- 
commissural distance. AHCWR was calculated throughout the cardiac cycle before and 
after infarction using SAL data. Results: Prior to infarction the normal annulus accentu- 
ated its saddle shape during systole with the AHCWR increasing from 0.118± 0.011 at 
end diastole to 0.157± 0.010 at mid-systole. After infarction this systolic accentuation 
was attenuated or totally obliterated in all sheep with the AHCWR decreasing from 
0.122± 0.017 at end diastole to 0.107± 0.011 at mid-systole (p<0.006-compered to pre 
infarction). Conclusion: This study documents for the first time, the dynamic nature of the 
mitral annular saddle shape throughout systole and links the loss of this shape to mitral 
valve incompetence. 
1012-134 Outcome of  Mitral  Surgery  in Pat ients  With Coronary 
Disease 
Peter S. Dahlbero. Thomas A. Orszulak, Charles J. Mullany, Maurice Enriquez-Sarano, 
Richard C. Daly, Hartzelt V. Schaff, Mayo Clinic, Rochester, Minnesota, University of 
Minnesota, Minneapolis, Minnesota. 
OBJECTIVE: To determine the influence of the etiology of mitral valvular regurgitation 
(MR) - ischemic or degenerative (deg)- on the outcome of surgery for patients undergo- 
ing combined mitral valve repair or replacement and coronary artery bypass grafting 
(CABG). 
METHODS: From 1987 to 1995, 239 patients underwent mitral valve repair or replace- 
ment and simultaneous CABG; mean age was 70 +/- 10, and 64% were men. Etiology of 
MR was ischemic when there was central MR with associated wall motion abnormalities. 
Patients with ruptured chordee were categorized as having dog MR. The endpoints of 
death, recurrence of NYHA class Ill/IV CHF or moderate MR were analyzed. 
RESULTS: The cause of MR was ischemic in 112 (47%) and dog in 127 (53%). Mean 
ejection fraction in the two groups were 39% and 60%, respectively. Fiffy-three (22%) 
valves were replaced and 186 (78%) were repaired. Median follow-up was 67 months, 
and the 10-year actuarial survival rates of patients with ischemic and dog MR were 31% 
and 49%, respectively. Univariate predictors of death, including an ischemic etiology of 
the MR, are listed in the table below. In multivariate analysis, however, etiology of MR 
was not an independent predictor of morality, subsequent NYHA class Ill/IV CHF, or 
recurrent MR. 
CONCLUSIONS: An ischemic etiology of MR is not an independent risk factor for death 
following MV surgery + CABG; rather, outcome is determined by the severity of preoper- 
ative symptoms and the extent of coronary disease and ventricular dysfunction. 
Remodeling Remodeling Emergency 
LV ejection fraction (%) 20_+8 47+14 <0.0001 NYHA Ill/IV 
LV end-diastolic diameter (ram) 67+9 58+9 <0.0001 EF < 35% 
% patients with 3 or 4+ MR 67 10 <0.0001 3-vessel CAD 
MV Apical tenting area (cm 2) 2.3 ± 0.9 1.35 ± 0.68 < 0.0001 Age > 72 yrs 
MV Apical tenting distance (mm) 9.9 ± 0.5 6.2 + 1.9 < 0.0001 LIMA 
Anterior mitral leaflet excursion angle 41 ± 10 49 + 12 < 0.0001 Ischemic 
(degrees) 
Posterior mitral leaflet excursion angle 27 ± 12 30 ± 10 0.02 
(degrees) 
MV annulus systolic diameter (mm) 36 ± 6 33 ± 5 0.003 
Inter papillary muscle distance (mm) 44 ± 8 34 ± 5 < 0.0001 
Left atrial diameter (mm) 51+8 45+7 0.0006 
There were no changes in mitral leaflet length or thickness. Threshold tenting area and 
distance values for 3 or 4+ MR were 2 cm 2 and 10 mm respectively. 
Conclusions: 1)LV size reduction in CHF results in centripetal movement of papillary 
muscles, a reduction in mitral leaflet tenting, an increase in leaflet mobility and to a lesser 
degree, reduction in mitral annulus size. 2)This reduces MR. 3)Stability of MV repair is 
likely to be affected by changes in LV geometry. 
Uni,2ariate* Multivariate Risk (CI)** Multivariate P 
<0.0001 0.68 (0.51-0.93) 0.017 
<0.0001 0.64 (0.45-0.88) 0.0049 
<0.0001 0.67 (0.53-0.84) 0.0009 
<0.0001 0.74 (0.59-0.91) 0.0042 
0.01 0.80 (0.66-0.97) 0.022 
0.0032 1.07 (0.87-1.3) 0.51 
0.006 1.t (0.90-1.4) 0.3 
*Kaplan-Meier **Proportional Hazards 
1012-1 35 I schemic  Mltral  Regurg i tat ion Is Independent  of  
Papillary Muscle Dysfunction: Clinical Demonstration 
by Quantitative Echocardiography in Patients With 
Inferior Myocardial Infarction 
Takeshi Uemura. Yutaka Otsuji, Toshiro Kumanohoso, Shiro Yoshituku, Akira Kisanuki, 
Shinichi Minagoe, Robert A. Levine, Chuwa Tel, Kagoshima University Kagoshima, 
Japan, Massachusetts General Hospital, Boston, Massachusetts. 
Background: Although papillary muscle (PM) contractile dysfunction alone has been 
demonstrated not to cause ischemic mitral regurgitation (MR) in animal experiments, the 
relation between PM dysfunction and ischemic MR in patients is controversial In princi- 
ple, PM dysfunction could be associated with increased MR because of remodeling of 
the underlying wall, increasing leaflet tethering; or with less MR because of PM elonga- 
tion, attenuating tethering. 
Methods: In 26 patients with previous inferior myocardial infarction and 10 controls, LV 
volume, ejection fraction (EF), mitral annular area, medial and lateral PM tethering dis- 
tanca (PM to annulus), %PM systolic thickening, and MR grade were evaluated by quan- 
titative Doppler echo. 
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eral pts had moderate MR despite normal thickening. 2) MR was correlated with LV and 
annular dilatation, reduced EF, and increased tethering, with the strongest independent 
contribution by multivariate analysis from increased medial PM tethering. 
Conclusions: Ischemic MR is independent of PM dysfunction but is related to geometric 
changes with medial PM tethering from LV remodeling in patients with infedor MI. 
~sw= r ,~=0.79 N~. 
. ~  o ~ o o o~ 
/o  h fMI  oZ, J "  [-oonvol oy ,  oo o, o 
i / i i i 
20 30 40 50 -20 0 20 4 
1012-136 End-Syato l i¢  Left  Ventr lcu lar  D iameter  > 45 mm in Mitral  
Regurg l te t lon  Is an Insens i t ive  Marker  o f  Left  
Ventrlcular Dysfunction and a Poor Predictor of 
Postoperat ive  Outcome 
Maurica Endouez-Sarano, Michael F. Bellamy, Thomas A. Orszulak, Hartzall V. Schaff, 
Mayo Clinic, Rochester, Minnesota. 
Background: Left ventdcular end-systolic diameter (LVS) has been touted as a good 
indicator of left ventricular (LV) dysfunction in mitral regurgitation (MR). Recent ACC/AHA 
guidelines recommend that LVS -> 45 mm be used for indication of surgery for MR. How- 
ever, this recommendation is based on limited evidence and its appropriateness is uncer- 
tain. 
Methods: We studied 676 consecutive patients who had LVS measurement prior to 
valve repair (447) or replacement for chronic mitral valve regurgitation; operations were 
performed between 1980 and 1995, and postoperative echocardiograrns were available 
in 589 patients. 
Results: Comparing the 116 (17%) patients with preoperative LVS _> 45 mm to the 560 
(83%) with LVS < 45 mm, age (63 + 12 vs. 64 + 14, P =0.54) and prevalence of class Ill- 
IV (57 vs. 53%, P--0.51) were not different. However, males (78 vs. 57%, P <0.0001) 
were over-raprasanted and ejection fraction (EF) was lower (49 ± 10 vs. 64 + 8%, P 
<0.0001). For outcome, with preoperative LVS > 45 ram, operative mortality was border- 
line higher (6 vs, 3%, P =0.14), 15-year survival was lower (22 + 7 vs. 38 ± 4%, P =0,007) 
and 15-year incidence of heart failure was higher (40 ± 7 vs. 30 + 4%, P =0.0002), How- 
ever, in multivariate analysis of survival and heart failure, LVS ~ 45 mm did not reach sta- 
tistical significance (both P >0.33) while EF remained independently predictive (P =0,02 
and P <0.001). Postoperative LV dysfunction (EF < 50%) was noted in 95 patients (64%) 
with LVS _> 45 mm and in 130 (26%) with LVS < 45 mm (P <0.001). After repair, LV dys- 
function was noted in 60% and 23% of patients with and without LVS _> 45 mm (P <0.001) 
and in 38% of patients with LVS 40-45 rnm. 
Conclusions: These data suggest that the recommendation that surgical correction of 
MR be performed when LVS is > 45 mm should be reconsidered. The cdterion is rarely 
observed in clinical practice, particularly in women, is a poor predictor of outcome, and 
LVS > 45 mm preoperatively is associated with substantial rates of postoperative LV dys- 
function. We do not advocate use of this critedon as a guide for intervening in patients 
with MR and believe that optimal survival and functional status is achieved by early opar- 
afion for patients with severe MR documented by quantitative methods. 
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1035-131 Coronary  Ar tery  Bypass  Grafting in Pat ients  With 
Dialysis-Dependent End Stage Renal Disease: A Nested 
Case-Cont ro l  Study 
Kevin L. Powstl, J. Michael Smith, Scott E. Woods, Mary Pat Handy, Good Samaritan 
Hospital, Cincinnati, Ohio, Bethesda Family Medicine Residency, Cincinnati, Ohio. 
Background - To prospectively assess if there are any outcomes differences for patients 
on dialysis for chronic renal failure (CRF) who are undergoing coronary artery by-pass 
surgery (CABG). 
Methods - We conducted a nested case-control study. Cases and controls came from a 
eight-year, prospective hospitalization cohort (N=5324). Inclusion in the cohort included 
CABG between 10/93 and 2/01 and age greater than eighteen. Exclusion cdteria include 
any simultaneously performed surgery with CABG. Data were collected on 140 variables 
concurrently with admission by physicians, nurses and parfusionists. Cases ware defined 
as patients on dialysis for CRF undergoing CABG (N=28). Each case was matched with 
three controls. Cases and controls were matched on four variables: age, gender, smok- 
ing history, and New York Heart Association Functional Classification. Controls ware 
defined as patients not on dialysis undergoing CABG (N=84). The ten outcomes of inter- 
est were mortality, intensive care unit length of stay, total length of hospitalization, time 
on the ventilator, wound complications, pulmonary and neurological complications, gas- 
trointestinal complications, arrhythmia, and intraogerative complications. Using logistic 
regression we controlled for thirteen potential confounding variables: race, hypertension, 
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diabetes, chronic obstructive pulmonary disease, pdor myocardial infarction, body sur- 
face area, hyparcholestarolemia, left vantdcular hypertrophy, character of operation, 
bleeding history, previous cardiac surgery, pulmonary hypartenion, and current vascular 
disease. 
Results -There were no significant differences between cases and controls for seven of 
the eight outcomes of interest including mortality (RR=0,97, 95% CI 0.23-4.01). Patients 
on dialysis had a significantly longer hospital stay. They stayed 21% longer than their 
matched controls(RR=1,21 95% CI 1.05-1.38). 
Conclusion - Patients on dialysis for CRF undergoing CABG surgery stay significantly 
longer in the hospital compared to non-dialysis patients. Other outcomes, including mor- 
tality, show no significant difference after controlling for multiple dsk factors, 
1035-132 Mul t ip le  Arter ia l  Graf ts  Improved  Surv iva l  Fo l low ing  
Coronary  Bypass  Surgery  
James H. O'Keefe. Jr., Kyle Fritz, Phillip Jones, Cardiovascular Consultants, PC, Kansas 
City, Missouri, Mid America Heart Institute, Kansas Ci~ Missouri. 
Background: The use of the left internal mammary artery (LIMA) as a conduit during cor- 
onary artery bypass graft surgery has been shown to improve outcomes over usa of 
saphenous vein grafts (SVGs). The use of Multiple Arterial grafts is becoming more com- 
mon, although the long-term mortality benefits over that achieved with the usa of LIMA 
are uncertain, 
Objective: To evaluate long-term outcome following coronary artery bypass graft surgery 
using: all SVGs, or a single LIMA with SVGs, or Multiple Artedal grafts during long-term 
follow up. 
Methods: A large prospectively collected comprehensive database was utilized to evalu- 
ate consecutive patients who underwent coronary artery bypass grafting. All patients who 
underwent a concommitant procedure such as valvular surgery, carotid surgery, etc. 
were excluded. Consecutive patients were utilized and regular prospectively collected 
follow up was obtained. The national death index was used for assessment of mortality 
status. 
Keplan-Meyar analysis was used to construct survival curves. A proportional hazards 
analysis was used to identity independent predictors of mortality, 
Results: A total of 2,967 patients were studied who underwent coronary artery bypass 
grafting between 1995 and 2000, Average follow up was approximately 30 months; mor- 
tality follow up was 99% complete. Patients in SVG group were older, had higher heart 
failure and angina functional scores and worse left vantdcular function compared to the 
LIMA and Multiple Arterial groups. 
Kaplan-Meyar survival was superior for the LIMA and Multiple Arterial groups at 24 
months (SVG=87%, LIMA=95%, Multiple Arteries=98%). The differences continued to 
widen at 38 months, To account for differing demographics in the groups, a multi-variable 
analysis was performed. This identified Multiple Artedes and LIMA to be both indepen- 
dent predictors of improved survival time during follow up. Other predictors of mortality 
include craatinine > 1.5 mg/dL, age, diabetes and congestive heart failure. 
Conclusion: Long term survival following bypass grafting is best with Multiple Arterial 
grafts, intermediate for LIMA with SVGs, and worst with all SVGs, 
1035-133 Emergent  and  Urgent  Coronary  Surgery  Af ter  
A t tempted  Percuteneous  Coronary  In tervent ion  (PCl): 
An Ana lys i s  of  the  NHLBI  Database In the Era of  Stents  
John T. Schindler, David O. Williams, David R. Holmes, Janet Johnston, Katherine M. 
Datra, Howard A. Cohen, CVI and GSPH University of Pittsburgh, Pittsburgh, 
Pennsylvania. 
Background: Prior to the widespread usa of stents, acute complications related to PCI 
frequently required coronary bypass surgery. The purpose of this study was to determine 
the need for emergent or urgent coronary bypass surgery after failed PCI in the current 
stent era. 
Methods: The National Heart, Blood and Lung Instituta's Dynamic Registry database of 
4,564 patients undergoing PCI at sixteen different medical centers was analyzed by com- 
bining two different waves of enrollment (July 1997-Feb 1998 - Feb 1999-June 1999). 
Thirty-seven (0.81%) patients were identified as requiring urgent or emergent coronary 
surgery after PCI. Upon review of the catheterization films, twenty-six (0.57%) patients 
fulfilled the criteria of undergoing failed PCI requiring subsequent coronary bypass sur- 
gery. Patients were categorized according to the need for emergent/urgent surgery as 
well as calculating outcome event rates for the patients requiring emergent/urgent sur- 
gery as compared to those with successful PCI. 
Results: The reason for requiring bypass surgery of the twenty-six patients were as fol- 
lows: 1 .) Thirteen patients with large coronary dissections not amenable to correction 
with stenting, 2.) Seven patients with total occlusions preventing successful passage of a 
guide wire and ongoing ischemia, 3.) Three patients with distal embolization and persis- 
tently reduced coronary flow, 4.) Two patients with coronary perforation, and 5.) One 
patient with stent dislodgment from the balloon into the left main coronary artery. Patients 
who required emergent/urgent surgery had a higher mortality (11.1% vs. 1.4% P<0.001), 
and an increased combined endpoint of death/nonfatal MI (18.5% vs. 4.0% p<0.001). 
Conclusions: Complications related to PCI that require emergent/urgent bypass surgery 
are relatively uncommon. Despite the widespread availability of coronary stenting, how- 
ever, one-half of the patients who required emergency surgery were secondary to targe 
dissections that were judged to be too complex for percutaneous treatment. PCI should 
be performed at centers with on-site cardiothoracic surgery availability in order to facili- 
tate emergency surgical intervention. 
